
The formula for bridging scientific advancement with operational flexibility in boosting access to cell and gene therapies.
Melissa Lattanzi is Vice President, Emerging Therapies for Cencora’s Strategic Global Sourcing team, responsible for product access, distribution strategy, and contracting and trade relations for the cell and gene therapy and biosimilar categories. She leads business development efforts and partners with companies during clinical development on distribution and channel considerations to ensure commercial success, collaborating with internal teams to ensure proper processes and infrastructure are in place to meet the unique needs of this growing category.

The formula for bridging scientific advancement with operational flexibility in boosting access to cell and gene therapies.